Immune checkpoint blockade in small cell lung cancer: is there a light at the end of the tunnel?

by Paglialunga, Luca, Salih, Zena, Ricciuti, Biagio, Califano, Raffaele
Published in ESMO Open (2016)

Targeting EGFR and ALK in NSCLC: current evidence and future perspective

by Bennati, Chiara, Paglialunga, Luca, Ricciuti, Biagio, Metro, Giulio, Marcomigni, Luca, Gili, Alessio, Crinò, Lucio
Published in Lung Cancer Manag (2016)

Osimertinib in patients with advanced epidermal growth factor receptor T790M mutation-positive non-small cell lung cancer: rationale, evidence and place in therapy

by Ricciuti, Biagio, Baglivo, Sara, Paglialunga, Luca, De Giglio, Andrea, Bellezza, Guido, Chiari, Rita, Crinò, Lucio, Metro, Giulio
Published in Ther Adv Med Oncol (2017)

miRNAs and resistance to EGFR—TKIs in EGFR-mutant non-small cell lung cancer: beyond ‘traditional mechanisms’ of resistance

by Ricciuti, Biagio, Mecca, Carmen, Cenci, Matteo, Leonardi, Giulia Costanza, Perrone, Lorenzo, Mencaroni, Clelia, Crinò, Lucio, Grignani, Francesco, Baglivo, Sara, Chiari, Rita, Sidoni, Angelo, Paglialunga, Luca, Currà, Maria Francesca, Murano, Emanuele, Minotti, Vincenzo, Metro, Giulio
Published in Ecancermedicalscience (2015)